The relationship between Receptor Activator of Nuclear Factor-.KAPPA.B Ligand (RANKL) gene polymorphism and aortic calcification in Korean women
- 1 January 2010
- journal article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 57 (6) , 541-549
Abstract
The aim of this study was to investigate the relationship between RANKL gene polymorphisms and aortic calcification in Korean women. In 237 healthy Korean women, aortic calcification in thoracic and abdominal aorta was examined in simple radiologic method and lumbar spine and femoral neck BMD were examined by dual energy X-ray absorptiometry. Serum OPG levels, bone turnover markers, such as ALP levels and urine deoxypyridinoline levels, and urine calcium excretion were measured. Genotyping of two RANKL gene polymorphisms, rs2277438 and rs9594782, was performed by allelic discrimination using the 5' nuclease polymerase chain reaction assay. The subjects with CT/CC genotypes of the rs9594782 polymorphism had a 3.9 times higher risk of aortic calcification compared with TT genotype. This significance was significant even after adjustment for age, BMI, blood pressure, fasting plasma glucose, serum high and low-density lipoprotein cholesterol levels. Mean levels of urine deoxypyridinoline were significantly higher in the subjects with AG/GG genotypes of the rs2277438 polymorphism compared with AA genotype, and this significance was persistent even after adjustment for age and BMI. There were no associations of mean values for age, BMI, serum OPG and ALP levels, urine calcium excretion, and BMD with RANKL gene polymorphisms. The RANKL gene rs9594782 polymorphism was associated with aortic calcification in Korean women. Rs2277438 polymorphism showed significant association with urine deoxypyridinoline levels, a bone resorption marker. These results suggest its role on vascular calcification and bone metabolism in humans.Keywords
This publication has 38 references indexed in Scilit:
- Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and OsteoprotegerinCirculation Research, 2004
- Clinical Implications of the Osteoprotegerin/RANKL/RANK System for Bone and Vascular DiseasesJAMA, 2004
- Aortic Calcification on Plain Chest Radiography Increases Risk for Coronary Artery DiseaseChest, 2002
- Calcification of the Aortic ArchJAMA, 2000
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLProceedings of the National Academy of Sciences, 1998
- Predominance of aortic calcification as an atherosclerotic manifestation in women: The Reykjavík studyJournal of Clinical Epidemiology, 1996
- Aortic calcified plaques and cardiovascular disease (the Framingham study)The American Journal of Cardiology, 1990
- AORTIC CALCIFICATION AS A PREDICTOR OF CARDIOVASCULAR MORTALITYThe Lancet, 1986
- Calcification of the Aorta and OsteoporosisJAMA, 1972